Literature DB >> 32949769

Otto Warburg: The journey towards the seminal discovery of tumor cell bioenergetic reprogramming.

Ana M Urbano1.   

Abstract

Metabolic reprogramming is now regarded as a hallmark of cancer. This phenomenon was first observed at the level of cellular energetics, in the form of very high rates of lactic acid fermentation, not only in anoxia, but also in the presence of oxygen levels that do not compromise respiration. This intriguing tumor phenotype, characterized by a very low energy yield, was unveiled, in the early 1920s, by Otto Warburg, one of the greatest biochemists of all time. This manuscript outlines aspects of Warburg's personal and research life that, in retrospect, might be viewed as a preparation for his successful approach to the cancer problem. It also discusses the experiments that led to the discovery and briefly presents Warburg's theory for the origin of tumors. Finally, it concludes with considerations regarding the novel avenues that this monumental and still intriguing discovery opened in terms of diagnosis and treatment of cancer.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerobic glycolysis; Early research career; Historical perspective; Metabolic reprogramming; Oncometabolism; Warburg effect

Mesh:

Substances:

Year:  2020        PMID: 32949769     DOI: 10.1016/j.bbadis.2020.165965

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Basis Dis        ISSN: 0925-4439            Impact factor:   5.187


  5 in total

1.  lncRNA-DANCR Promotes Taxol Resistance of Prostate Cancer Cells through Modulating the miR-33b-5p-LDHA Axis.

Authors:  Yu-Yong Wang; Chao Chen
Journal:  Dis Markers       Date:  2022-05-04       Impact factor: 3.464

Review 2.  Nematode-Applied Technology for Human Tumor Microenvironment Research and Development.

Authors:  Eric di Luccio; Satoru Kaifuchi; Nobuaki Kondo; Ryota Chijimatsu; Andrea Vecchione; Takaaki Hirotsu; Hideshi Ishii
Journal:  Curr Issues Mol Biol       Date:  2022-02-21       Impact factor: 2.976

3.  Propofol modulates glycolysis reprogramming of ovarian tumor via restraining circular RNA-zinc finger RNA-binding protein/microRNA-212-5p/superoxide dismutase 2 axis.

Authors:  DongDong Qu; Xin Zou; ZhiLin Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 4.  Role of hypoxia in the tumor microenvironment and targeted therapy.

Authors:  Gaoqi Chen; Kaiwen Wu; Hao Li; Demeng Xia; Tianlin He
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 5.  Role of reactive oxygen species in tumors based on the 'seed and soil' theory: A complex interaction (Review).

Authors:  Wei Liang; Xinying He; Jianqiang Bi; Tingting Hu; Yunchuan Sun
Journal:  Oncol Rep       Date:  2021-07-30       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.